[U.S. DEPARTMENT OF DEFENSE - Tick-Borne Disease Idea Award | Research funding]
Event details
| Date | 25.06.2018 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Tick-Borne Disease Research Program (TBDRP) for 2018. The intent of the TBDRP Idea Award intends to support conceptually innovative, high-risk/potentially high-reward research in the early stages of development that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals affected by Lyme disease and/or other tick-borne illnesses. This award mechanism promotes new ideas that represent innovative approaches to Lyme disease and other tick-borne diseases research and have the potential to make an important contribution toward the TBDRP mission.
Applications submitted to the FY18 TBDRP must address at least one of the specific Focus Areas in Lyme disease and other tick-borne diseases with emphasis on reducing public health burden. These Focus Areas are listed at the end of this announcement.
Funding: Maximum USD $ 250’000
Duration: 2 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at the level of Assistant Professor or higher are eligible to submit applications.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a proposal narrative, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 25 June 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 27 September 2018, 11:59 p.m. EST (05:59 28 Sep, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-TBDRP-IA
Further information
Focus Areas FY18 TBDRP
Applications submitted to the FY18 TBDRP must address at least one of the specific Focus Areas in Lyme disease and other tick-borne diseases with emphasis on reducing public health burden. These Focus Areas are listed at the end of this announcement.
Funding: Maximum USD $ 250’000
Duration: 2 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at the level of Assistant Professor or higher are eligible to submit applications.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a proposal narrative, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 25 June 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 27 September 2018, 11:59 p.m. EST (05:59 28 Sep, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-TBDRP-IA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-18-TBDRP-IA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
Focus Areas FY18 TBDRP
- Diagnosis
- Accurate diagnostics for Lyme disease and co-infections and/or other tick-borne diseases
- Biomarkers to identify tick-borne diseases or their products in humans
- Diagnostic biomarkers for Lyme disease that distinguish between active infection and previous exposure, and/or monitor response to treatment
- Pathogenesis
- Understanding the immunological mechanisms of immune protection for Lyme disease or other tick-borne diseases
- Understanding the complex biology of Lyme borrelia in the host (beyond in vitro studies), including its survival, evasion of the host immune system, and subversion of the effectiveness of antibiotics
- Biomarkers that aid in exploring underlying mechanisms of persistent symptoms associated with Lyme disease
- Treatment
- Antibiotic combinations and/or therapeutic options for treating acute and persistent illness
- Prevention
- Identification, validation, and/or improvement of tick-targeted prevention and control interventions
- Human vaccines for tick-borne diseases
Practical information
- General public
- Free